Thymidine labeling index and Ki-67 growth fraction in breast cancer: comparison and correlation with prognosis. 1994

M Rudas, and M F Gnant, and M Mittlböck, and R Neumayer, and A Kummer, and R Jakesz, and G Reiner, and A Reiner
Institute for Clinical Pathology, University of Vienna, Austria.

In situ determination of proliferative activity was performed on 184 consecutive primary invasive breast cancers. Methods used were monoclonal antibody Ki-67 in immunohistochemistry and thymidine labeling index. Tumor proliferation correlated between both methods (p = 0.0001). For thymidine labeling index and Ki-67, respectively, significant correlations existed with histologic tumour grade and steroid hormone receptors (Tumor grade: TLI p = 0.0001; Ki-67 p = 0.0001. ER-ICA: TLI = 0.0001; Ki-67 p = 0.014. PgR-ICA: TLI p = 0.0001; Ki-67 p = 0.0008). For thymidine labeling index a significant correlation was demonstrated for overall survival (p = 0.001) and recurrence free survival (p = 0.01). No statistical significance was observed for clinical outcome and Ki-67 (overall survival p = 0.18; recurrence free survival p = 0.1). None of the factors, TLI or Ki-67, was an independent prognostic factor as demonstrated by multivariate analysis.

UI MeSH Term Description Entries
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004261 DNA Replication The process by which a DNA molecule is duplicated. Autonomous Replication,Replication, Autonomous,Autonomous Replications,DNA Replications,Replication, DNA,Replications, Autonomous,Replications, DNA
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Rudas, and M F Gnant, and M Mittlböck, and R Neumayer, and A Kummer, and R Jakesz, and G Reiner, and A Reiner
January 1989, The American journal of pathology,
M Rudas, and M F Gnant, and M Mittlböck, and R Neumayer, and A Kummer, and R Jakesz, and G Reiner, and A Reiner
April 1991, American journal of clinical pathology,
M Rudas, and M F Gnant, and M Mittlböck, and R Neumayer, and A Kummer, and R Jakesz, and G Reiner, and A Reiner
December 1989, Tumori,
M Rudas, and M F Gnant, and M Mittlböck, and R Neumayer, and A Kummer, and R Jakesz, and G Reiner, and A Reiner
September 2012, Nihon rinsho. Japanese journal of clinical medicine,
M Rudas, and M F Gnant, and M Mittlböck, and R Neumayer, and A Kummer, and R Jakesz, and G Reiner, and A Reiner
January 2015, Radiology,
M Rudas, and M F Gnant, and M Mittlböck, and R Neumayer, and A Kummer, and R Jakesz, and G Reiner, and A Reiner
February 2015, Clinical breast cancer,
M Rudas, and M F Gnant, and M Mittlböck, and R Neumayer, and A Kummer, and R Jakesz, and G Reiner, and A Reiner
August 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
M Rudas, and M F Gnant, and M Mittlböck, and R Neumayer, and A Kummer, and R Jakesz, and G Reiner, and A Reiner
January 2002, Surgery today,
M Rudas, and M F Gnant, and M Mittlböck, and R Neumayer, and A Kummer, and R Jakesz, and G Reiner, and A Reiner
December 2002, Applied immunohistochemistry & molecular morphology : AIMM,
M Rudas, and M F Gnant, and M Mittlböck, and R Neumayer, and A Kummer, and R Jakesz, and G Reiner, and A Reiner
January 2018, Journal of Ayub Medical College, Abbottabad : JAMC,
Copied contents to your clipboard!